Enhabit (EHAB) Competitors $6.53 -0.19 (-2.83%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$6.64 +0.11 (+1.75%) As of 08/1/2025 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EHAB vs. AHCO, AGL, PNTG, AVAH, CDNA, FTRE, PSNL, FLGT, CELC, and INNVShould you be buying Enhabit stock or one of its competitors? The main competitors of Enhabit include AdaptHealth (AHCO), Agilon Health (AGL), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), CareDx (CDNA), Fortrea (FTRE), Personalis (PSNL), Fulgent Genetics (FLGT), Celcuity (CELC), and InnovAge (INNV). These companies are all part of the "healthcare" industry. Enhabit vs. Its Competitors AdaptHealth Agilon Health The Pennant Group Aveanna Healthcare CareDx Fortrea Personalis Fulgent Genetics Celcuity InnovAge Enhabit (NYSE:EHAB) and AdaptHealth (NASDAQ:AHCO) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends. Does the media refer more to EHAB or AHCO? In the previous week, AdaptHealth had 3 more articles in the media than Enhabit. MarketBeat recorded 4 mentions for AdaptHealth and 1 mentions for Enhabit. AdaptHealth's average media sentiment score of 0.94 beat Enhabit's score of 0.00 indicating that AdaptHealth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enhabit 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AdaptHealth 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of EHAB or AHCO? 82.7% of AdaptHealth shares are owned by institutional investors. 3.4% of Enhabit shares are owned by insiders. Comparatively, 1.6% of AdaptHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, EHAB or AHCO? AdaptHealth has higher revenue and earnings than Enhabit. Enhabit is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnhabit$1.03B0.32-$156.20M-$2.77-2.36AdaptHealth$3.26B0.36$90.42M$0.5715.35 Which has more volatility and risk, EHAB or AHCO? Enhabit has a beta of 1.68, meaning that its stock price is 68% more volatile than the S&P 500. Comparatively, AdaptHealth has a beta of 1.58, meaning that its stock price is 58% more volatile than the S&P 500. Is EHAB or AHCO more profitable? AdaptHealth has a net margin of 2.63% compared to Enhabit's net margin of -13.43%. AdaptHealth's return on equity of 6.96% beat Enhabit's return on equity.Company Net Margins Return on Equity Return on Assets Enhabit-13.43% 2.02% 0.94% AdaptHealth 2.63%6.96%2.40% Do analysts rate EHAB or AHCO? Enhabit currently has a consensus target price of $8.75, suggesting a potential upside of 34.00%. AdaptHealth has a consensus target price of $13.40, suggesting a potential upside of 53.14%. Given AdaptHealth's stronger consensus rating and higher probable upside, analysts clearly believe AdaptHealth is more favorable than Enhabit.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enhabit 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50AdaptHealth 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryAdaptHealth beats Enhabit on 14 of the 16 factors compared between the two stocks. Get Enhabit News Delivered to You Automatically Sign up to receive the latest news and ratings for EHAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EHAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EHAB vs. The Competition Export to ExcelMetricEnhabitMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$340.28M$7.18B$5.49B$20.63BDividend YieldN/A2.90%4.73%3.67%P/E Ratio-2.3664.1328.8329.01Price / Sales0.3233.83372.0766.10Price / Cash1.6425.7735.4522.82Price / Book0.608.618.274.43Net Income-$156.20M$239.96M$3.25B$993.74M7 Day Performance-3.19%-5.48%-3.73%-3.39%1 Month Performance-15.30%-3.73%4.29%-2.10%1 Year Performance-32.54%18.27%25.87%10.09% Enhabit Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EHABEnhabit2.5465 of 5 stars$6.53-2.8%$8.75+34.0%-35.0%$340.28M$1.03B-2.3610,700Upcoming EarningsAHCOAdaptHealth3.9844 of 5 stars$9.59+1.6%$13.40+39.7%-21.2%$1.27B$3.26B16.8210,500Upcoming EarningsAGLAgilon Health1.6556 of 5 stars$1.99-3.4%$4.71+136.9%-74.2%$852.74M$6.06B-3.371,076Upcoming EarningsPNTGThe Pennant Group3.5784 of 5 stars$23.22-0.6%$33.80+45.6%-26.2%$804.85M$695.24M30.557,000Positive NewsUpcoming EarningsAVAHAveanna Healthcare1.4944 of 5 stars$3.95-0.3%$5.25+32.9%-10.1%$772.57M$2.02B197.5033,500News CoverageUpcoming EarningsGap DownCDNACareDx4.1626 of 5 stars$12.79flat$29.33+129.3%-48.2%$712.15M$333.79M11.12740Positive NewsUpcoming EarningsAnalyst DowngradeFTREFortrea4.1139 of 5 stars$6.87+1.0%$14.00+103.8%-80.4%$615.40M$2.70B-0.7815,500Trending NewsUpcoming EarningsGap UpPSNLPersonalis3.8477 of 5 stars$6.15-5.2%$7.67+24.7%+51.0%$573.23M$84.61M-4.77400Upcoming EarningsGap DownFLGTFulgent Genetics4.2937 of 5 stars$18.02-1.9%$24.00+33.2%-21.4%$559.25M$283.47M-13.551,313News CoverageCELCCelcuity0.8633 of 5 stars$36.79+167.2%$39.20+6.6%+122.5%$521.42MN/A-12.1440Insider TradeAnalyst RevisionHigh Trading VolumeINNVInnovAge1.8138 of 5 stars$3.75-2.3%$5.00+33.3%-48.1%$518.45M$831.68M-16.302,350News Coverage Related Companies and Tools Related Companies AHCO Competitors AGL Competitors PNTG Competitors AVAH Competitors CDNA Competitors FTRE Competitors PSNL Competitors FLGT Competitors CELC Competitors INNV Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EHAB) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enhabit, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enhabit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
